financetom
Business
financetom
/
Business
/
Google must face part of US consumer lawsuit over search dominance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Google must face part of US consumer lawsuit over search dominance
Jan 17, 2025 8:31 AM

Jan 17 (Reuters) - Google has failed to persuade a judge

in California to throw out a lawsuit accusing the technology

giant of monopolizing the online search market.

San Francisco-based U.S. District Judge Rita Lin in a ruling

on Thursday said consumers can proceed for now with allegations

that the Alphabet unit's business practices hampered

the development of high-quality rival search engines.

The lawsuit filed in 2022, accused Google of unlawfully

scheming with Apple ( AAPL ) to make Google the exclusive

preloaded default search engine on the iPhone maker's devices.

Lin dismissed other claims in the lawsuit related to

Google's text advertising and said the plaintiffs could not

include Google chief executive Sundar Pichai and the Alphabet

unit's former chief Eric Schmidt as defendants.

Google and attorneys for the 26 consumers who filed the

lawsuit did not immediately respond to requests for comment.

Google has denied any wrongdoing. Apple ( AAPL ) is not a defendant.

Lin's latest ruling comes after the plaintiffs amended their

complaint following a ruling in August against Google by a

federal judge in Washington, D.C.

In that decision, U.S. District Judge Amit Mehta found that

Google's exclusive contracts with Apple ( AAPL ) and other companies

helped it create an illegal monopoly over search engines.

Google countered that the D.C. judge's order, which the

company is fighting, does not help the consumer plaintiffs in

the California case. Google said the consumers' lawsuit rested

on unfounded allegations.

Lin said the plaintiffs had shown enough detail to contend

that Google's exclusive contracts for default status have hurt

market competition.

At this stage in the case, Lin wrote, the consumers' claims

support their conclusion that in a more competitive market

"viable search alternatives would have emerged that offer

greater privacy protections or are less clogged with ads."

Lin set the next hearing in the case for Feb. 12.

The case is Arcell v. Google LLC, U.S. District Court,

Northern District of California, No. 22-cv-02499-RFL.

For plaintiffs: Joseph Alioto of Alioto Law Firm, and

Lawrence Papale of Law Office of Lawrence Papale

For Google: John Schmidtlein and Carol Pruski of Williams &

Connolly

Read more:

Apple ( AAPL ) seeks to defend Google's billion-dollar payments in

search case

Google offers to loosen search deals in US antitrust case

remedy

Google's US antitrust trial over online ad empire draws to a

close

Why the US forced sale of Google's Chrome faces legal

hurdles

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US CFPB drops enforcement action against Capital One
US CFPB drops enforcement action against Capital One
Feb 27, 2025
(Reuters) - The U.S. Consumer Financial Protection Bureau on Thursday dropped a legal action against Capital One, which the agency had accused last month of cheating consumers out of more than $2 billion in interest payments on savings accounts. The dismissal continues President Donald Trump's rapid moves to dismantle the agency, which he has said should be eliminated, but came...
Zevra Therapeutics to Sell Priority Review Voucher for $150 Million
Zevra Therapeutics to Sell Priority Review Voucher for $150 Million
Feb 27, 2025
11:11 AM EST, 02/27/2025 (MT Newswires) -- Zevra Therapeutics ( ZVRA ) said Thursday it has signed a deal to sell its rare pediatric disease priority review voucher for $150 million, with transaction expected within 30 to 45 days. Zevra was granted the voucher in September last year following Miplyffa approval by the US Food and Drug Administration. Shares of...
Bath & Body Works Fourth-Quarter Sales Decline; 2025 Earnings Outlook Disappoints
Bath & Body Works Fourth-Quarter Sales Decline; 2025 Earnings Outlook Disappoints
Feb 27, 2025
11:14 AM EST, 02/27/2025 (MT Newswires) -- Bath & Body Works ( BBWI ) on Thursday reported a year-year-year drop in fiscal fourth-quarter sales, while the retailer offering body care products and home fragrances set expectations for a likely earnings decline this year. Revenue fell to $2.79 billion for the three months ended Feb. 1 from $2.91 billion the year...
Cassava Sciences Licenses Simufilam Patent From Yale University for Potential Treatment of Seizures; Shares Rise
Cassava Sciences Licenses Simufilam Patent From Yale University for Potential Treatment of Seizures; Shares Rise
Feb 27, 2025
11:14 AM EST, 02/27/2025 (MT Newswires) -- Cassava Sciences ( SAVA ) said Thursday it has entered into a license agreement with Yale University for intellectual property rights, including an exclusive US method of treatment patent covering simufilam as a potential treatment for seizures linked to rare neurodevelopmental disorders such as tuberous sclerosis complex. The licensed patent is based on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved